NKG2D recognizes and kills infected cells and cancer cells by targeting up to eight stress-induced ligands (NKG2DL), namely MICA, MICB, and ULBP [1–6] that are overexpressed on viral infected, DNA-damaged or transformed cells, and not usually expressed in healthy tissues [12, 13]. The gene discussed is KLRK1; the disease is cancer.